Synthesis 2010(1): 115-119  
DOI: 10.1055/s-0029-1217096
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Stereoselective Synthesis and Biological Studies of the C2 and C3 Epimer and the Enantiomer of Pachastrissamine (Jaspine B)

G. Jayachitraa, N. Sudhakara, Ravi Kumar Anchooria, B. Venkateswara Rao*a, Sayantani Royb, Rajkumar Banerjeeb
a Organic Division III, Indian Institute of Chemical Technology, Hyderabad 500007, India
Fax: +91(40)27193003; e-Mail: venky@iict.res.in;
b Lipid Science and Technology, Indian Institute of Chemical Technology, Hyderabad 500007, India
Further Information

Publication History

Received 11 August 2009
Publication Date:
03 November 2009 (online)

Abstract

The synthesis of the C2 and C3 epimer and also the enantiomer of jaspine B from d-glucose is reported. The cytotoxicity of these isomers along with jaspine B and its C2 epimer on MCF7 cells has been correlated with commercially available anticancer drug Epirubicin.

    References

  • 1 Kuroda I. Musman M. Ohtani II. Ichiba T. Tanaka J. Gravalos DG. Higa T. J. Nat. Prod.  2002,  65:  1505 
  • 2 Ledroit V. Debitus C. Lavaud C. Massiot G. Tetrahedron Lett.  2003,  44:  225 
  • 3 Bubb MR. Senderowicz AMJ. Sausville EA. Duncan KLK. Korn ED. J. Biol. Chem.  1994,  269:  14869 
  • 4 Kobayashi J. Murata O. Shigemori H. J. Nat. Prod.  1993,  56:  787 
  • 5 Zabriskie TM. Ireland CM. J. Nat. Prod.  1989,  52:  1353 
  • 6 Zampella A. Giannini C. Debitus C. Roussakis C. D’Auria MV. J. Nat. Prod.  1999,  62:  332 
  • For reviews, see:
  • 7a Koskinen PM. Synthesis  1998,  1075 
  • 7b Curfman C. Liotta D. Methods Enzymol.  1999,  311:  391 
  • 8a Sudhakar N. Kumar AR. Prabhakar A. Jagadeesh B. Rao BV. Tetrahedron Lett.  2005,  46:  325 
  • 8b Bhaket P. Morris K. Stauffer CS. Datta A. Org. Lett.  2005,  7:  875 
  • 8c Chandrasekhar S. Tiwari B. Prakash SJ. ARKIVOC  2006,  (xi):  155 
  • 8d Van den Berg RJBHN. Boltje TJ. Verhagen CP. Litjens REJN. Van der Marel GA. Overkleef HS. J. Org. Chem.  2006,  71:  836 
  • 8e Du Y. Liu J. Linhardt RJ. J. Org. Chem.  2006,  71:  1251 
  • 8f Lee T. Lee S. Kwak YS. Kim D. Kim S. Org. Lett.  2007,  9:  429 
  • 8g Passiniemi M. Koskinen AMP. Tetrahedron Lett.  2008,  49:  980 
  • 8h Reddy LVR. Reddy PV. Shaw AK. Tetrahedron: Asymmetry  2007,  18:  542 
  • 8i Ramana CV. Giri AG. Suryawanshi SB. Gonnade RG. Tetrahedron Lett.  2007,  48:  265 
  • 8j Ribes C. Falomir E. Carda M. Marco JA. Tetrahedron  2006,  62:  5421 
  • 8k Prasad KR. Chandrakumar A. J. Org. Chem.  2007,  72:  6312 
  • 8l Abraham E. Candela-Lena JI. Davies SG. Georgiou M. Nicholson RL. Roberts PM. Russell AJ. Sanchez-Fernandez EM. Smith AD. Thomson JE. Tetrahedron: Asymmetry  2007,  18:  2510 
  • 8m Abraham E. Brock EA. Candela-Lena JH. Roberts PM. Russell AJ. Sanchez-Fernandez EM. Scott PM. Smith AD. Thomson JE. Org. Biomol. Chem.  2008,  6:  1665 
  • 8n Yakura T. Sato S. Yoshimoto Y. Chem. Pharm. Bull.  2007,  55:  1284 
  • 8o Venkatesan K. Srinivasan KV. Tetrahedron: Asymmetry  2008,  19:  209 
  • 8p Canals D. Mormeneo D. Fabrias G. Llebaria A. Bioorg. Med. Chem.  2009,  17:  235 
  • 8q For reviews, see: Abraham E. Davies SG. Roberts PM. Russell AJ. Thomson JE. Tetrahedron: Asymmetry  2008,  19:  1027 
  • 9a Reist EJ. Spencer RR. Baker BR. J. Org. Chem.  1958,  23:  1958 
  • 9b Molas MP. Matheu MI. Castillon S. Isac-Garcia J. Hernandez-Mateo F. Calvo-Flores FG. Santoyo-Gonzalez F. Tetrahedron  1999,  55:  14649 
  • 9c Tsuda Y. Noguchi S. Niino H. Chem. Pharm. Bull.  2001,  49:  1210 
  • 9d Roy BG. Roy A. Achari B. Mandal SB. Tetrahedron Lett.  2006,  47:  7783 
  • 9e Maity JK. Mukherjee S. Drew MGB. Achari B. Mandal SB. Carbohydr. Res.  2007,  342:  2511 
  • 10 The spectral data of the compound 3a obtained were in accordance with the reported values, but the optical rotation for the reported compound is [α]D ²5 -2.58p where as we observed it as [α]D ²8 +3.1